Colin Pettis

Colin Pettis covers the senior semiconductor sector and is a managing director at Tech Insider, joining in 2012. Colin has 20 years of experience in equity research including 15 years in semiconductor components. Colin is currently responsible for the coverage of 18 large-cap and small-cap semiconductor companies.

Communication Equipment: Nokia Corporation (ADR) (NYSE:NOK), QUALCOMM (NASDAQ:QCOM), Alcatel Lucent (NYSE:ALU), JDS Uniphase Corp (NASDAQ:JDSU)

Nokia Corporation (ADR) (NYSE:NOK) suffered a jolt when the Supreme Court refused to lift the restraint on sale of its Indian assets, including the Chennai plant, as part of the handset maker’s global deal with the Microsoft. The apex court dismissed Nokia’s plea against the Delhi High Court order directing its parent company in Finland…

Read More

Gainers On Major News: Yahoo! Inc. (NASDAQ:YHOO), Moody’s Corporation (NYSE:MCO), Keurig Green Mountain (NASDAQ:GMCR), Market Vector Russia (NYSEARCA:RSX)

Yahoo Inc. (NASDAQ:YHOO) owns a big stake in Alibaba, which is expected to go public later this year in one of the most anticipated public offerings in tech. Last month, after the company reported better-than-expected revenue, analysts estimated that Alibaba’s valuation could go as high as $153 billion. Yahoo! Inc. (NASDAQ:YHOO) stock performance was 0.99%…

Read More
FB Nasdaq FB Facebook

Gainers At NYSE: Companhia Siderurgica Nacional (NYSE:SID), GameStop Corp. (NYSE:GME), Generac Holdings (NYSE:GNRC), Spirit Realty Capital (New) (NYSE:SRC)

Companhia Siderurgica Nacional (NYSE:SID) is a Brazil-based company primarily engaged in the steel industry. The Company divides its business into five segments: Steel sector, which is involved in the production, distribution and marketing of flat steel, galvanized steel and metal packaging. Companhia Siderurgica Nacional (ADR) (NYSE:SID) stock performance was 12.64% in last session and finished…

Read More

Biotech Unusual Volume: Tengion (OTCMKTS:TNGN), Alseres Pharmaceuticals (OTCMKTS:ALSE), Fate Therapeutics (NASDAQ:FATE), Synthetic Biologics (NYSEMKT:SYN)

Tengion, Inc. (OTCMKTS:TNGN) on Mar. 3 issued notices to the holders (the “2012 Investors”) of senior secured notes issued on October 2, 2012 and to the holders (the “2013 Investors” and together with the 2012 Investors, the “Investors” and each, an “Investor”) of senior secured notes issued on June 28, 2013 stating that the Company…

Read More

Biotech Stocks New Highs: Fate Therapeutics (NASDAQ:FATE), Synthetic Biologics (NYSEMKT:SYN), Celladon Corp (NASDAQ:CLDN), Kindred Biosciences (NASDAQ:KIN)

Fate Therapeutics, Inc. (NASDAQ:FATE) announced that it has enrolled the first patient in its phase II study (PUMA − P rohema in UM bilical cord blood transplant in A dults) on Prohema. Fate Therapeutics Inc. (NASDAQ:FATE) stock performance was 27.14% in last session and finished the day at $11.15. Traded volume was 295,227.00 shares in…

Read More

Small Cap Volatile Stocks: Allied Nevada Gold (NYSEMKT:ANV), Sandstorm Gold (NYSEMKT:SAND), Unilife Corp (NASDAQ:UNIS), Gray Television (NYSE:GTN)

West Kirkland Mining Inc. (TSX VENTURE:WKM) cautions investors that any forward-looking information provided by the Company is not a guarantee of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to, the state of the financial markets…

Read More